Healthequity (HQY) Cash from Financing Activities (2013 - 2026)

Healthequity's Cash from Financing Activities history runs 14 years deep, the most recent figure standing at -$137.2 million for Q2 2026.

• On a quarterly basis, Cash from Financing Activities fell 142.16% year-over-year to -$137.2 million in Q2 2026; TTM through Apr 2026 was -$467.5 million, a 819.33% decrease from a year earlier, with the FY2026 full-year figure at -$387.0 million, down 772.22% from the prior year.
• Cash from Financing Activities fell to -$137.2 million in Q2 2026 per HQY's latest filing, from -$99.8 million in the prior quarter.
• Across five years, Cash from Financing Activities topped out at $176.6 million in Q3 2024 and bottomed at -$137.2 million in Q2 2026.
• The 5-year median for Cash from Financing Activities is -$3.2 million (2022), against an average of -$28.8 million.
• Biggest YoY gain for Cash from Financing Activities was 8295.68% in 2024; the steepest drop was 4163.86% in 2024.
• Year by year, Cash from Financing Activities stood at -$1.1 million in 2022, then soared by 285.21% to $2.0 million in 2023, then plunged by 4163.86% to -$82.4 million in 2024, then slumped by 48.51% to -$122.4 million in 2025, then decreased by 12.08% to -$137.2 million in 2026.
• Per Business Quant, the three latest HQY Cash from Financing Activities figures stand at -$137.2 million (Q2 2026), -$99.8 million (Q1 2026), and -$122.4 million (Q4 2025).